|
US4181803A
(en)
*
|
1973-12-14 |
1980-01-01 |
Eisai Co., Ltd. |
Propiophenone derivatives and preparation thereof
|
|
DE3337593A1
(de)
|
1982-10-27 |
1984-05-03 |
Degussa Ag, 6000 Frankfurt |
2-amino-3-acylamino-6-benzylamino-pyridin-derivate mit antiepileptischer wirkung
|
|
ATE25078T1
(de)
*
|
1982-10-27 |
1987-02-15 |
Degussa |
2-amino-3-acylamino-6-benzylamino-pyridinderivate mit anti-epileptischer wirkung.
|
|
EP0189788B1
(de)
|
1985-01-23 |
1989-09-13 |
ASTA Pharma Aktiengesellschaft |
Synergistische Kombination von Flupirtin und nicht-steroidalen Antiphlogistika
|
|
EP0193056B1
(de)
*
|
1985-02-23 |
1989-06-07 |
ASTA Pharma Aktiengesellschaft |
Kombination von Flupirtin und anticholinergisch wirkenden Spasmolytika
|
|
DE3604575A1
(de)
|
1985-02-23 |
1986-08-28 |
Degussa Ag, 6000 Frankfurt |
Kombination von flupirtin und anticholinergisch wirkenden spasmolytika
|
|
JP2583067B2
(ja)
*
|
1987-08-04 |
1997-02-19 |
住友化学工業株式会社 |
モノアゾ化合物およびそれを用いて疎水性繊維材料を染色または捺染する方法
|
|
GB8800199D0
(en)
*
|
1988-01-06 |
1988-02-10 |
Beecham Group Plc |
Pharmaceutical preparation
|
|
MC2029A1
(fr)
*
|
1988-05-16 |
1990-04-25 |
Asta Pharma Ag |
(n-heterocyclyl)-3 diamino-2,6 pyridines substituees et leurs n-oxydes,preparation de ces composes et leur application comme medicaments
|
|
US5629307A
(en)
*
|
1989-10-20 |
1997-05-13 |
Olney; John W. |
Use of ibogaine in reducing excitotoxic brain damage
|
|
US6004945A
(en)
*
|
1990-05-10 |
1999-12-21 |
Fukunaga; Atsuo F. |
Use of adenosine compounds to relieve pain
|
|
IN172468B
(online.php)
*
|
1990-07-14 |
1993-08-14 |
Asta Medica Ag |
|
|
US5643921A
(en)
*
|
1990-09-26 |
1997-07-01 |
E.R. Squibb & Sons, Inc. |
Cardiopulmonary bypass and organ transplant using a potassium channel activator
|
|
US5234947A
(en)
*
|
1991-11-07 |
1993-08-10 |
New York University |
Potassium channel activating compounds and methods of use thereof
|
|
DE4200259A1
(de)
*
|
1992-01-08 |
1993-07-15 |
Asta Medica Ag |
Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
|
|
US5262419A
(en)
*
|
1992-06-11 |
1993-11-16 |
E. R. Squibb & Sons, Inc. |
Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
|
|
CA2115792C
(en)
*
|
1993-03-05 |
2005-11-01 |
David J. Mayer |
Method for the treatment of pain
|
|
US5428039A
(en)
*
|
1994-02-20 |
1995-06-27 |
The Center For Innovative Technology |
Method for electively achieving reversible hyperpolarized cardiac arrest
|
|
AU3162695A
(en)
*
|
1994-08-03 |
1996-03-04 |
Asta Medica Aktiengesellschaft |
Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects
|
|
JP4097285B2
(ja)
*
|
1994-09-22 |
2008-06-11 |
リチャード・アラン・スミス |
種々の頑固な疾患の治療のための医薬の製造に有用な組成物
|
|
US5679706A
(en)
*
|
1994-09-30 |
1997-10-21 |
Bristol-Myers Squibb Company |
Combination of a potassium channel activator and an antiarrhythmic agent
|
|
WO1996019233A2
(en)
*
|
1994-12-12 |
1996-06-27 |
Omeros Medical Systems, Inc. |
Irrigation solution and method for inhibition of pain, inflammation and spasm
|
|
DE19539861A1
(de)
*
|
1995-10-26 |
1997-04-30 |
Asta Medica Ag |
Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
|
|
DE19701694A1
(de)
*
|
1997-01-20 |
1998-07-23 |
Asta Medica Ag |
Neue Modifikationen des 2-Amino-4-(4-fluorbenzylamino)-l-ethoxycarbonyl-aminobenzen sowie Verfahren zu ihrer Herstellung
|
|
IN188411B
(online.php)
*
|
1997-03-27 |
2002-09-21 |
Yuhan Corp |
|
|
US5760007A
(en)
*
|
1997-07-16 |
1998-06-02 |
Ortho Pharmaceutical Corporation |
Anticonvulsant derivatives useful in treating neuropathic pain
|
|
DE69832176T2
(de)
*
|
1997-08-08 |
2006-08-03 |
Chugai Seiyaku K.K. |
Arzneimittel gegen diabetes-komplikationen
|
|
US6593335B1
(en)
*
|
1997-12-18 |
2003-07-15 |
Abbott Laboratories |
Potassium channel openers
|
|
US6265417B1
(en)
*
|
1997-12-18 |
2001-07-24 |
Abbott Laboratories |
Potassium channel openers
|
|
US6211171B1
(en)
*
|
1998-05-19 |
2001-04-03 |
Dalhousie University |
Use of antidepressants for local analgesia
|
|
JP3441970B2
(ja)
|
1998-06-30 |
2003-09-02 |
株式会社サミー |
豆腐の製造方法及び製造装置
|
|
JP2000143510A
(ja)
|
1998-11-16 |
2000-05-23 |
Taisho Pharmaceut Co Ltd |
外用組成物
|
|
WO2000035434A2
(en)
*
|
1998-12-14 |
2000-06-22 |
Cellegy Pharmaceuticals, Inc. |
Compositions and methods for the treatment of anorectal disorders
|
|
US6281211B1
(en)
*
|
1999-02-04 |
2001-08-28 |
Euro-Celtique S.A. |
Substituted semicarbazides and the use thereof
|
|
GB9903476D0
(en)
*
|
1999-02-17 |
1999-04-07 |
Zeneca Ltd |
Therapeutic agents
|
|
JP2002538221A
(ja)
*
|
1999-03-10 |
2002-11-12 |
ワーナー−ランバート・カンパニー |
抗てんかん作用を有する化合物を包含する鎮痛組成物およびその使用方法
|
|
CA2367895A1
(en)
|
1999-03-17 |
2000-09-21 |
Signal Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
|
AT409083B
(de)
*
|
1999-04-01 |
2002-05-27 |
Sanochemia Pharmazeutika Ag |
Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
|
|
US6610324B2
(en)
|
1999-04-07 |
2003-08-26 |
The Mclean Hospital Corporation |
Flupirtine in the treatment of fibromyalgia and related conditions
|
|
GB9915414D0
(en)
|
1999-07-01 |
1999-09-01 |
Glaxo Group Ltd |
Medical use
|
|
CN1230174C
(zh)
|
1999-07-06 |
2005-12-07 |
伊莱利利公司 |
治疗偏头痛的选择性iGluR5受体拮抗剂
|
|
US6472165B1
(en)
*
|
1999-08-03 |
2002-10-29 |
Arzneimittelwerk Dresden Gmbh |
Modulatory binding site in potassium channels for screening and finding new active ingredients
|
|
JP2003506387A
(ja)
*
|
1999-08-04 |
2003-02-18 |
アイカゲン インコーポレイテッド |
カリウムチャンネルオープナーとしてのベンズアニリド
|
|
NZ527771A
(en)
*
|
1999-08-04 |
2005-04-29 |
Icagen Inc |
Methods for treating or preventing anxiety
|
|
US6495550B2
(en)
*
|
1999-08-04 |
2002-12-17 |
Icagen, Inc. |
Pyridine-substituted benzanilides as potassium ion channel openers
|
|
US6117900A
(en)
|
1999-09-27 |
2000-09-12 |
Asta Medica Aktiengesellschaft |
Use of retigabine for the treatment of neuropathic pain
|
|
US6383511B1
(en)
*
|
1999-10-25 |
2002-05-07 |
Epicept Corporation |
Local prevention or amelioration of pain from surgically closed wounds
|
|
US6538004B2
(en)
*
|
2000-03-03 |
2003-03-25 |
Abbott Laboratories |
Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
|
|
US20020015730A1
(en)
*
|
2000-03-09 |
2002-02-07 |
Torsten Hoffmann |
Pharmaceutical formulations and method for making
|
|
TWI287984B
(en)
*
|
2000-10-17 |
2007-10-11 |
Wyeth Corp |
Pharmaceutical composition for modulating bladder function
|
|
US6589986B2
(en)
*
|
2000-12-20 |
2003-07-08 |
Wyeth |
Methods of treating anxiety disorders
|
|
US6951863B2
(en)
*
|
2001-02-07 |
2005-10-04 |
Ortho-Mcneil Pharmaceutical, Inc. |
Pyridoarylphenly oxazolidinone antibacterials, and related compositions and methods
|
|
US6469042B1
(en)
*
|
2001-02-20 |
2002-10-22 |
Bristol-Myers Squibb Company |
Fluoro oxindole derivatives as modulators if KCNQ potassium channels
|
|
AR033095A1
(es)
*
|
2001-04-04 |
2003-12-03 |
Wyeth Corp |
Metodos para el tratamiento de motilidad gastrica hiperactiva
|
|
GB0121214D0
(en)
|
2001-08-31 |
2001-10-24 |
Btg Int Ltd |
Synthetic method
|
|
US6831087B2
(en)
*
|
2001-11-09 |
2004-12-14 |
Hoffmann-La Roche Inc. |
Pyridine substituted isoquinoline derivatives
|
|
US7375222B2
(en)
*
|
2002-02-05 |
2008-05-20 |
Astellas Pharma Inc. |
2,4,6-Triamino-1,3,5-triazine derivative
|
|
AU2003202115A1
(en)
*
|
2002-02-12 |
2003-09-04 |
Pfizer Inc. |
Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
|
|
ATE533743T1
(de)
|
2002-05-17 |
2011-12-15 |
Janssen Pharmaceutica Nv |
Harnstoffderivate von aminotetralin als modulatoren des vanilloid-rezeptors vr1
|
|
WO2003106454A1
(en)
|
2002-06-12 |
2003-12-24 |
Orchid Chemicals & Pharmaceuticals Ltd |
1h-isoquinoline-oxazolidinone derivaties and their use as antibacterial agents
|
|
AUPS312602A0
(en)
*
|
2002-06-21 |
2002-07-18 |
James Cook University |
Organ arrest, protection, preservation and recovery
|
|
US7419981B2
(en)
*
|
2002-08-15 |
2008-09-02 |
Pfizer Inc. |
Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
|
|
AU2003294441A1
(en)
*
|
2002-11-22 |
2004-06-18 |
Bristol-Myers Squibb Company |
1-aryl-2-hydroxyethyl amides as potassium channel openers
|
|
ATE488231T1
(de)
*
|
2002-12-23 |
2010-12-15 |
Icagen Inc |
Quinazolinone als kaliumkanalmodulatoren
|
|
WO2004058739A1
(en)
|
2002-12-27 |
2004-07-15 |
H. Lundbeck A/S |
1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system
|
|
BRPI0408205A
(pt)
|
2003-03-14 |
2006-02-14 |
Lundbeck & Co As H |
derivado de anilina substituìdo, composição farmacêutica, e, uso de uma composição farmacêutica
|
|
EP1613303A1
(en)
|
2003-03-21 |
2006-01-11 |
H. Lundbeck A/S |
Substituted p-diaminobenzene derivatives
|
|
AU2004233941A1
(en)
|
2003-04-25 |
2004-11-11 |
H. Lundbeck A/S |
Sustituted indoline and indole derivatives
|
|
US20060241134A1
(en)
|
2003-05-27 |
2006-10-26 |
Altana Pharma Ga |
Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
|
|
US7276608B2
(en)
*
|
2003-07-11 |
2007-10-02 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
|
EP1663239A4
(en)
*
|
2003-09-10 |
2008-07-23 |
Cedars Sinai Medical Center |
KALIUM CHANNEL-MEDIATED FEEDING OF MEDICINES BY THE BLOOD BRAIN BARRIER
|
|
US20050089559A1
(en)
*
|
2003-10-23 |
2005-04-28 |
Istvan Szelenyi |
Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
|
|
DE10359335A1
(de)
|
2003-10-23 |
2005-05-25 |
Viatris Gmbh & Co. Kg |
Kombinationen aus Kaliumkanalöffnern und Natriumkanalinhibitoren oder Natriumkanal beeinflussenden Wirkstoffen zur Behandlung von Schmerzzuständen
|
|
ES2235626B1
(es)
|
2003-11-10 |
2006-11-01 |
Almirall Prodesfarma, S.A. |
Formas de administracion masticables, no comprimidas dosificadas individualmente.
|
|
TW200530235A
(en)
*
|
2003-12-24 |
2005-09-16 |
Renovis Inc |
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
|
|
TWI349666B
(en)
|
2004-03-12 |
2011-10-01 |
Lundbeck & Co As H |
Substituted morpholine and thiomorpholine derivatives
|
|
AU2005233642A1
(en)
|
2004-04-13 |
2005-10-27 |
Astellas Pharma Inc. |
Polycyclic pyridines as potassium ion channel modulators
|
|
EP1748776A1
(en)
*
|
2004-05-03 |
2007-02-07 |
Duke University |
Compositions for affecting weight loss
|
|
WO2006006741A1
(ja)
*
|
2004-07-15 |
2006-01-19 |
Japan Tobacco Inc. |
縮合ベンズアミド化合物及びバニロイド受容体１型(ｖｒ１)活性阻害剤
|
|
UA89503C2
(uk)
|
2004-09-13 |
2010-02-10 |
Х. Луннбек А/С |
Заміщені похідні аніліну
|
|
CN101083985A
(zh)
*
|
2004-09-21 |
2007-12-05 |
幸讬制药公司 |
用于炎症及免疫相关用途的化合物
|
|
JPWO2006054513A1
(ja)
|
2004-11-19 |
2008-05-29 |
キッセイ薬品工業株式会社 |
神経因性疼痛の予防又は治療剤
|
|
EP1688141A1
(en)
*
|
2005-01-31 |
2006-08-09 |
elbion AG |
The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
|
|
CA2599890C
(en)
|
2005-03-03 |
2011-05-03 |
H. Lundbeck A/S |
Substituted pyridine derivatives
|
|
US7683058B2
(en)
*
|
2005-09-09 |
2010-03-23 |
H. Lundbeck A/S |
Substituted pyrimidine derivatives
|
|
US8148535B2
(en)
*
|
2005-10-21 |
2012-04-03 |
Merck Sharp & Dohme Corp. |
Potassium channel inhibitors
|
|
BRPI0716715B1
(pt)
|
2006-08-23 |
2021-07-06 |
Xenon Pharmaceuticals, Inc |
Derivados de 4-(n-azacicloalquil) anilidas como moduladores de canal de potássio, seus usos, produto, composição, comprimido e cápsula
|
|
US8030518B2
(en)
|
2006-11-28 |
2011-10-04 |
Valeant Pharmaceuticals International |
1,4 diamino bicyclic retigabine analogues as potassium channel modulators
|
|
US8563566B2
(en)
*
|
2007-08-01 |
2013-10-22 |
Valeant Pharmaceuticals International |
Naphthyridine derivatives as potassium channel modulators
|
|
CA2765678A1
(en)
*
|
2009-06-22 |
2010-12-29 |
Christopher Blackburn |
Substituted hydroxamic acids and uses thereof
|